Observational study suggests hormone therapy safe for postmenopausal BRCA mutation carriers
Monday, October 6, 2008 - 01:49
in Health & Medicine
The use of hormone therapy was associated with a reduced risk of breast cancer in postmenopausal women who carry BRCA mutations, according to a case-control study published online 23 September in the Journal of the National Cancer Institute...
Read the whole article on Science Centric
More from Science Centric
Related
- Also in the Jan. 27 JNCITue, 27 Jan 2009, 20:45:14 EST
- Women with BRCA mutation, or worry, most likely to undergo prophylactic mastectomyMon, 9 Mar 2009, 0:37:41 EDT
- Meta-analysis confirms value of risk-reducing salpingo-oophorectomy for women with BRCA mutationsWed, 14 Jan 2009, 4:38:00 EST
- A break from hormone therapy doesn't improve mammogramsMon, 1 Jun 2009, 17:29:18 EDT
- Mutation of BRCA gene influences women's views of preventive mastectomyMon, 9 Mar 2009, 0:37:47 EDT